F L Wolters

Summary

Affiliation: VieCuri Medical Center
Country: The Netherlands

Publications

  1. pmc Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort
    F L Wolters
    Department of Gastroenterology and Hepatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Gut 55:510-8. 2006
  2. pmc Phenotype at diagnosis predicts recurrence rates in Crohn's disease
    F L Wolters
    Department of Gastroenterology and Hepatology, University Hospital Maastricht, The Netherlands
    Gut 55:1124-30. 2006
  3. doi request reprint Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease
    M J L Romberg-Camps
    Department of Gastroenterology and Hepatology, Maastricht University Medical Center, University of Maastricht, The Netherlands
    Am J Gastroenterol 104:371-83. 2009
  4. ncbi request reprint Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease
    B P J van Balkom
    Department of Gastroenterology, University Hospital Maastricht, NL 6202 AZ Maastricht, The Netherlands
    Aliment Pharmacol Ther 16:1101-7. 2002
  5. ncbi request reprint Systematic review: has disease outcome in Crohn's disease changed during the last four decades?
    F L Wolters
    Department of Gastroenterology and Hepatology, University Hospital Maastricht, Maastricht, The Netherlands
    Aliment Pharmacol Ther 20:483-96. 2004
  6. pmc Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis
    O Hoie
    Sorlandet Hospital Arendal, Department of Medicine, Section for Gastroenterology, Arendal, Norway
    Gut 56:497-503. 2007

Collaborators

  • John Mouzas
  • T Bernklev
  • I A Mouzas
  • A Qasim
  • Bjørn Moum
  • Severine Vermeire
  • R W Stockbrugger
  • M J L Romberg-Camps
  • O Hoie
  • M G V M Russel
  • B P J van Balkom
  • A D M Kester
  • L G J B Engels
  • C Van deursen
  • M A M Hesselink-van de Kruijs
  • M Cilissen
  • W H A Hameeteman
  • P C Dagnelie
  • L Riis
  • M Vatn
  • P Politi
  • E Langholz
  • I C Solberg
  • L J Schouten
  • S Odes
  • H M van Dullemen
  • S J H van Deventer
  • E J Schoon
  • B Oldenburg
  • R A Van Hogezand

Detail Information

Publications6

  1. pmc Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort
    F L Wolters
    Department of Gastroenterology and Hepatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Gut 55:510-8. 2006
    ..We assessed the predictive value of phenotype at diagnosis on overall and disease related mortality in a European cohort of CD patients...
  2. pmc Phenotype at diagnosis predicts recurrence rates in Crohn's disease
    F L Wolters
    Department of Gastroenterology and Hepatology, University Hospital Maastricht, The Netherlands
    Gut 55:1124-30. 2006
    ..In Crohn's disease (CD), studies associating phenotype at diagnosis and subsequent disease activity are important for patient counselling and health care planning...
  3. doi request reprint Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease
    M J L Romberg-Camps
    Department of Gastroenterology and Hepatology, Maastricht University Medical Center, University of Maastricht, The Netherlands
    Am J Gastroenterol 104:371-83. 2009
    ..The aim of this study was to evaluate such factors in a population-based IBD group...
  4. ncbi request reprint Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease
    B P J van Balkom
    Department of Gastroenterology, University Hospital Maastricht, NL 6202 AZ Maastricht, The Netherlands
    Aliment Pharmacol Ther 16:1101-7. 2002
    ..Infusion of anti-tumour necrosis factor-alpha appears to be highly effective in patients with Crohn's disease...
  5. ncbi request reprint Systematic review: has disease outcome in Crohn's disease changed during the last four decades?
    F L Wolters
    Department of Gastroenterology and Hepatology, University Hospital Maastricht, Maastricht, The Netherlands
    Aliment Pharmacol Ther 20:483-96. 2004
    ..Disease outcome measurement in Crohn's disease has methodological difficulties because of patient selection and lack of proper definition of diagnostic and outcome measurement criteria...
  6. pmc Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis
    O Hoie
    Sorlandet Hospital Arendal, Department of Medicine, Section for Gastroenterology, Arendal, Norway
    Gut 56:497-503. 2007
    ..Population based studies have revealed varying mortality for patients with ulcerative colitis but most have described patients from limited geographical areas who were diagnosed before 1990...